Melanie Coverage Analysis Software

During development and manufacturing of biopharmaceuticals, host cell protein (HCP) impurities must be carefully identified and monitored to guarantee patient safety and drug efficacy. Melanie™ Coverage puts a powerful tool in the hands of scientists developing or utilizing immunoassays such as enzyme-linked immunosorbent assays (ELISA) to monitor HCP impurities in biopharmaceutical products.